Table of Contents 1 Market Overview 1.1 Gaucher Disease Introduction 1.2 Market Analysis by Type 1.2.1 Enzyme replacement therapy 1.2.2 Substrate reduction therapy 1.3 Market Analysis by Applications 1.3.1 Non-neuronopathic Gaucher disease 1.3.2 Neuronopathic Gaucher disease 1.4 Market Analysis by Regions 1.4.1 North America (USA, Canada and Mexico) 1.4.1.1 USA Market States and Outlook (2012-2022) 1.4.1.2 Canada Market States and Outlook (2012-2022) 1.4.1.3 Mexico Market States and Outlook (2012-2022) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2012-2022) 1.4.2.2 France Market States and Outlook (2012-2022) 1.4.2.3 UK Market States and Outlook (2012-2022) 1.4.2.4 Russia Market States and Outlook (2012-2022) 1.4.2.5 Italy Market States and Outlook (2012-2022) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2012-2022) 1.4.3.2 Japan Market States and Outlook (2012-2022) 1.4.3.3 Korea Market States and Outlook (2012-2022) 1.4.3.4 India Market States and Outlook (2012-2022) 1.4.3.5 Southeast Asia Market States and Outlook (2012-2022) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2012-2022) 1.4.4.2 Egypt Market States and Outlook (2012-2022) 1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022) 1.4.4.4 South Africa Market States and Outlook (2012-2022) 1.4.4.5 Nigeria Market States and Outlook (2012-2022) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Sanofi 2.1.1 Business Overview 2.1.2 Gaucher Disease Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 Sanofi Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Shire 2.2.1 Business Overview 2.2.2 Gaucher Disease Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Shire Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Actelion Pharma 2.3.1 Business Overview 2.3.2 Gaucher Disease Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Actelion Pharma Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Pfizer 2.4.1 Business Overview 2.4.2 Gaucher Disease Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Pfizer Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 ISU Pharm 2.5.1 Business Overview 2.5.2 Gaucher Disease Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 ISU Pharm Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Gaucher Disease Market Competition, by Manufacturer 3.1 Global Gaucher Disease Sales and Market Share by Manufacturer 3.2 Global Gaucher Disease Revenue and Market Share by Manufacturer 3.3 Market Concentration Rate 3.3.1 Top 3 Gaucher Disease Manufacturer Market Share 3.3.2 Top 6 Gaucher Disease Manufacturer Market Share 3.4 Market Competition Trend 4 Global Gaucher Disease Market Analysis by Regions 4.1 Global Gaucher Disease Sales, Revenue and Market Share by Regions 4.1.1 Global Gaucher Disease Sales by Regions (2012-2017) 4.1.2 Global Gaucher Disease Revenue by Regions (2012-2017) 4.2 North America Gaucher Disease Sales and Growth (2012-2017) 4.3 Europe Gaucher Disease Sales and Growth (2012-2017) 4.4 Asia-Pacific Gaucher Disease Sales and Growth (2012-2017) 4.5 South America Gaucher Disease Sales and Growth (2012-2017) 4.6 Middle East and Africa Gaucher Disease Sales and Growth (2012-2017) 5 North America Gaucher Disease by Countries 5.1 North America Gaucher Disease Sales, Revenue and Market Share by Countries 5.1.1 North America Gaucher Disease Sales by Countries (2012-2017) 5.1.2 North America Gaucher Disease Revenue by Countries (2012-2017) 5.2 USA Gaucher Disease Sales and Growth (2012-2017) 5.3 Canada Gaucher Disease Sales and Growth (2012-2017) 5.4 Mexico Gaucher Disease Sales and Growth (2012-2017) 6 Europe Gaucher Disease by Countries 6.1 Europe Gaucher Disease Sales, Revenue and Market Share by Countries 6.1.1 Europe Gaucher Disease Sales by Countries (2012-2017) 6.1.2 Europe Gaucher Disease Revenue by Countries (2012-2017) 6.2 Germany Gaucher Disease Sales and Growth (2012-2017) 6.3 UK Gaucher Disease Sales and Growth (2012-2017) 6.4 France Gaucher Disease Sales and Growth (2012-2017) 6.5 Russia Gaucher Disease Sales and Growth (2012-2017) 6.6 Italy Gaucher Disease Sales and Growth (2012-2017) 7 Asia-Pacific Gaucher Disease by Countries 7.1 Asia-Pacific Gaucher Disease Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific Gaucher Disease Sales by Countries (2012-2017) 7.1.2 Asia-Pacific Gaucher Disease Revenue by Countries (2012-2017) 7.2 China Gaucher Disease Sales and Growth (2012-2017) 7.3 Japan Gaucher Disease Sales and Growth (2012-2017) 7.4 Korea Gaucher Disease Sales and Growth (2012-2017) 7.5 India Gaucher Disease Sales and Growth (2012-2017) 7.6 Southeast Asia Gaucher Disease Sales and Growth (2012-2017) 8 South America Gaucher Disease by Countries 8.1 South America Gaucher Disease Sales, Revenue and Market Share by Countries 8.1.1 South America Gaucher Disease Sales by Countries (2012-2017) 8.1.2 South America Gaucher Disease Revenue by Countries (2012-2017) 8.2 Brazil Gaucher Disease Sales and Growth (2012-2017) 8.3 Argentina Gaucher Disease Sales and Growth (2012-2017) 8.4 Columbia Gaucher Disease Sales and Growth (2012-2017) 9 Middle East and Africa Gaucher Disease by Countries 9.1 Middle East and Africa Gaucher Disease Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Gaucher Disease Sales by Countries (2012-2017) 9.1.2 Middle East and Africa Gaucher Disease Revenue by Countries (2012-2017) 9.2 Saudi Arabia Gaucher Disease Sales and Growth (2012-2017) 9.3 UAE Gaucher Disease Sales and Growth (2012-2017) 9.4 Egypt Gaucher Disease Sales and Growth (2012-2017) 9.5 Nigeria Gaucher Disease Sales and Growth (2012-2017) 9.6 South Africa Gaucher Disease Sales and Growth (2012-2017) 10 Global Gaucher Disease Market Segment by Type 10.1 Global Gaucher Disease Sales, Revenue and Market Share by Type (2012-2017) 10.1.1 Global Gaucher Disease Sales and Market Share by Type (2012-2017) 10.1.2 Global Gaucher Disease Revenue and Market Share by Type (2012-2017) 10.2 Enzyme replacement therapy Sales Growth and Price 10.2.1 Global Enzyme replacement therapy Sales Growth (2012-2017) 10.2.2 Global Enzyme replacement therapy Price (2012-2017) 10.3 Substrate reduction therapy Sales Growth and Price 10.3.1 Global Substrate reduction therapy Sales Growth (2012-2017) 10.3.2 Global Substrate reduction therapy Price (2012-2017) 11 Global Gaucher Disease Market Segment by Application 11.1 Global Gaucher Disease Sales Market Share by Application (2012-2017) 11.2 Non-neuronopathic Gaucher disease Sales Growth (2012-2017) 11.3 Neuronopathic Gaucher disease Sales Growth (2012-2017) 12 Gaucher Disease Market Forecast (2017-2022) 12.1 Global Gaucher Disease Sales, Revenue and Growth Rate (2017-2022) 12.2 Gaucher Disease Market Forecast by Regions (2017-2022) 12.2.1 North America Gaucher Disease Market Forecast (2017-2022) 12.2.2 Europe Gaucher Disease Market Forecast (2017-2022) 12.2.3 Asia-Pacific Gaucher Disease Market Forecast (2017-2022) 12.2.4 South America Gaucher Disease Market Forecast (2017-2022) 12.2.5 Middle East and Africa Gaucher Disease Market Forecast (2017-2022) 12.3 Gaucher Disease Market Forecast by Type (2017-2022) 12.4 Gaucher Disease Market Forecast by Application (2017-2022) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Analyst Introduction 15.3 Data Source

List of Tables and Figures Figure Gaucher Disease Picture Table Product Specifications of Gaucher Disease Figure Global Sales Market Share of Gaucher Disease by Types in 2016 Table Gaucher Disease Types for Major Manufacturers Figure Enzyme replacement therapy Picture Figure Substrate reduction therapy Picture Table Gaucher Disease Sales Market Share by Applications in 2016 Figure Non-neuronopathic Gaucher disease Picture Figure Neuronopathic Gaucher disease Picture Figure USA Gaucher Disease Revenue (Value) and Growth Rate (2012-2022) Figure Canada Gaucher Disease Revenue (Value) and Growth Rate (2012-2022) Figure Mexico Gaucher Disease Revenue (Value) and Growth Rate (2012-2022) Figure Germany Gaucher Disease Revenue (Value) and Growth Rate (2012-2022) Figure France Gaucher Disease Revenue (Value) and Growth Rate (2012-2022) Figure UK Gaucher Disease Revenue (Value) and Growth Rate (2012-2022) Figure Russia Gaucher Disease Revenue (Value) and Growth Rate (2012-2022) Figure Italy Gaucher Disease Revenue (Value) and Growth Rate (2012-2022) Figure China Gaucher Disease Revenue (Value) and Growth Rate (2012-2022) Figure Japan Gaucher Disease Revenue (Value) and Growth Rate (2012-2022) Figure Korea Gaucher Disease Revenue (Value) and Growth Rate (2012-2022) Figure India Gaucher Disease Revenue (Value) and Growth Rate (2012-2022) Figure Southeast Asia Gaucher Disease Revenue (Value) and Growth Rate (2012-2022) Figure Brazil Gaucher Disease Revenue (Value) and Growth Rate (2012-2022) Figure Egypt Gaucher Disease Revenue (Value) and Growth Rate (2012-2022) Figure Saudi Arabia Gaucher Disease Revenue (Value) and Growth Rate (2012-2022) Figure South Africa Gaucher Disease Revenue (Value) and Growth Rate (2012-2022) Figure Nigeria Gaucher Disease Revenue (Value) and Growth Rate (2012-2022) Table Sanofi Basic Information, Manufacturing Base and Competitors Table Sanofi Gaucher Disease Type and Applications Table Sanofi Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Shire Basic Information, Manufacturing Base and Competitors Table Shire Gaucher Disease Type and Applications Table Shire Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Actelion Pharma Basic Information, Manufacturing Base and Competitors Table Actelion Pharma Gaucher Disease Type and Applications Table Actelion Pharma Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Gaucher Disease Type and Applications Table Pfizer Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table ISU Pharm Basic Information, Manufacturing Base and Competitors Table ISU Pharm Gaucher Disease Type and Applications Table ISU Pharm Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Global Gaucher Disease Sales by Manufacturer (2016-2017) Figure Global Gaucher Disease Sales Market Share by Manufacturer in 2016 Figure Global Gaucher Disease Sales Market Share by Manufacturer in 2017 Table Global Gaucher Disease Revenue by Manufacturer (2016-2017) Figure Global Gaucher Disease Revenue Market Share by Manufacturer in 2016 Figure Global Gaucher Disease Revenue Market Share by Manufacturer in 2017 Figure Global Gaucher Disease Sales and Growth (2012-2017) Figure Global Gaucher Disease Revenue and Growth (2012-2017) Table Global Gaucher Disease Sales by Regions (2012-2017) Table Global Gaucher Disease Sales Market Share by Regions (2012-2017) Table Global Gaucher Disease Revenue by Regions (2012-2017) Table Global Gaucher Disease Revenue Market Share by Regions in 2012 Table Global Gaucher Disease Revenue Market Share by Regions in 2016 Figure North America Gaucher Disease Sales and Growth (2012-2017) Figure Europe Gaucher Disease Sales and Growth (2012-2017) Figure Asia-Pacific Gaucher Disease Sales and Growth (2012-2017) Figure South America Gaucher Disease Sales and Growth (2012-2017) Figure Middle East and Africa Gaucher Disease Sales and Growth (2012-2017) Figure North America Gaucher Disease Revenue and Growth (2012-2017) Table North America Gaucher Disease Sales by Countries (2012-2017) Table North America Gaucher Disease Sales Market Share by Countries (2012-2017) Figure North America Gaucher Disease Sales Market Share by Countries in 2012 Figure North America Gaucher Disease Sales Market Share by Countries in 2016 Table North America Gaucher Disease Revenue by Countries (2012-2017) Table North America Gaucher Disease Revenue Market Share by Countries (2012-2017) Figure North America Gaucher Disease Revenue Market Share by Countries in 2012 Figure North America Gaucher Disease Revenue Market Share by Countries in 2016 Figure USA Gaucher Disease Sales and Growth (2012-2017) Figure Canada Gaucher Disease Sales and Growth (2012-2017) Figure Mexico Gaucher Disease Sales and Growth (2012-2017) Figure Europe Gaucher Disease Revenue and Growth (2012-2017) Table Europe Gaucher Disease Sales by Countries (2012-2017) Table Europe Gaucher Disease Sales Market Share by Countries (2012-2017) Table Europe Gaucher Disease Revenue by Countries (2012-2017) Table Europe Gaucher Disease Revenue Market Share by Countries in 2012 Table Europe Gaucher Disease Revenue Market Share by Countries in 2016 Figure Germany Gaucher Disease Sales and Growth (2012-2017) Figure UK Gaucher Disease Sales and Growth (2012-2017) Figure France Gaucher Disease Sales and Growth (2012-2017) Figure Russia Gaucher Disease Sales and Growth (2012-2017) Figure Italy Gaucher Disease Sales and Growth (2012-2017) Figure Asia-Pacific Gaucher Disease Revenue and Growth (2012-2017) Table Asia-Pacific Gaucher Disease Sales by Countries (2012-2017) Table Asia-Pacific Gaucher Disease Sales Market Share by Countries (2012-2017) Table Asia-Pacific Gaucher Disease Sales Market Share by Countries (2012-2017) Table Asia-Pacific Gaucher Disease Revenue by Countries (2012-2017) Table Asia-Pacific Gaucher Disease Revenue Market Share by Countries (2012-2017) Figure China Gaucher Disease Sales and Growth (2012-2017) Figure Japan Gaucher Disease Sales and Growth (2012-2017) Figure Korea Gaucher Disease Sales and Growth (2012-2017) Figure India Gaucher Disease Sales and Growth (2012-2017) Figure Southeast Asia Gaucher Disease Sales and Growth (2012-2017) Figure South America Gaucher Disease Revenue and Growth (2012-2017) Table South America Gaucher Disease Sales by Countries (2012-2017) Table South America Gaucher Disease Sales Market Share by Countries (2012-2017) Figure South America Gaucher Disease Sales Market Share by Countries in 2016 Table South America Gaucher Disease Revenue by Countries (2012-2017) Table South America Gaucher Disease Revenue Market Share by Countries (2012-2017) Figure South America Gaucher Disease Revenue Market Share by Countries in 2012 Figure South America Gaucher Disease Revenue Market Share by Countries in 2016 Figure Brazil Gaucher Disease Sales and Growth (2012-2017) Figure Argentina Gaucher Disease Sales and Growth (2012-2017) Figure Columbia Gaucher Disease Sales and Growth (2012-2017) Figure Middle East and Africa Gaucher Disease Revenue and Growth (2012-2017) Table Middle East and Africa Gaucher Disease Sales by Countries (2012-2017) Table Middle East and Africa Gaucher Disease Sales Market Share by Countries (2012-2017) Figure Middle East and Africa Gaucher Disease Sales Market Share by Countries in 2016 Table Middle East and Africa Gaucher Disease Revenue by Countries (2012-2017) Table Middle East and Africa Gaucher Disease Revenue Market Share by Countries (2012-2017) Figure Middle East and Africa Gaucher Disease Revenue Market Share by Countries in 2012 Figure Middle East and Africa Gaucher Disease Revenue Market Share by Countries in 2016 Figure Saudi Arabia Gaucher Disease Sales and Growth (2012-2017) Figure UAE Gaucher Disease Sales and Growth (2012-2017) Figure Egypt Gaucher Disease Sales and Growth (2012-2017) Figure Nigeria Gaucher Disease Sales and Growth (2012-2017) Figure South Africa Gaucher Disease Sales and Growth (2012-2017) Table Global Gaucher Disease Sales by Type (2012-2017) Table Global Gaucher Disease Sales Share by Type (2012-2017) Table Global Gaucher Disease Revenue by Type (2012-2017) Table Global Gaucher Disease Revenue Share by Type (2012-2017) Figure Global Enzyme replacement therapy Sales Growth (2012-2017) Figure Global Enzyme replacement therapy Price (2012-2017) Figure Global Substrate reduction therapy Sales Growth (2012-2017) Figure Global Substrate reduction therapy Price (2012-2017) Table Global Gaucher Disease Sales by Application (2012-2017) Table Global Gaucher Disease Sales Share by Application (2012-2017) Figure Global Non-neuronopathic Gaucher disease Sales Growth (2012-2017) Figure Global Neuronopathic Gaucher disease Sales Growth (2012-2017) Figure Global Gaucher Disease Sales, Revenue and Growth Rate (2017 -2022) Table Global Gaucher Disease Sales Forecast by Regions (2017-2022) Table Global Gaucher Disease Market Share Forecast by Regions (2017-2022) Figure North America Sales Gaucher Disease Market Forecast (2017-2022) Figure Europe Sales Gaucher Disease Market Forecast (2017-2022) Figure Asia-Pacific Sales Gaucher Disease Market Forecast (2017-2022) Figure South America Sales Gaucher Disease Market Forecast (2017-2022) Figure Middle East and Africa Sales Gaucher Disease Market Forecast (2017-2022) Table Global Gaucher Disease Sales Forecast by Type (2017-2022) Table Global Gaucher Disease Market Share Forecast by Type (2017-2022) Table Global Gaucher Disease Sales Forecast by Application (2017-2022) Table Global Gaucher Disease Market Share Forecast by Application (2017-2022) Table Distributors/Traders/ Dealers List